UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q
Amendment No. 1

(Mark One)

x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: June 30, 2008

o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period _________ to____________

Commission file number: 000-51248

OPTIGENEX INC.
(Exact name of small business issuer as specified in its charter)

Delaware
20-1678933
(State or other jurisdiction of
(IRS Employer I.D. Number)
incorporation or organization)
 

1170 Valley Brook Avenue, 2 nd Floor Suite B, Lyndhurst, NJ 07071
(Address of principal executive offices)

(201) 355-2098
(Issuer’s telephone number)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, and accelerated file, a non-accelerated filer, or a smaller reporting company.

Large accelerated filer o
Accelerated filer o
   
Non-accelerated filer o  (Do not check if a smaller reporting company)
Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  o No x

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS:

Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 of 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes o No o

APPLICABLE ONLY TO CORPORATE ISSUERS:

There were 66,533,776 shares of Common Stock outstanding as of July 28, 2008.
 


PART I

Optigenex Inc. is referred to as “we”, “our” or “us”
 
EXPLANATORY NOTE
 
Form 10-Q/A
 
Amendment #1
 
On August 4, 2008, we filed our Form 10-Q for the quarterly period ended June 30, 2008. On September 19, 2008, we received a comment letter from the Securities and Exchange Commission’s Division of Corporation Finance (“the SEC”) regarding our internal control over financial reporting. As a result of this comment letter, we reassessed our internal control over financial reporting, specifically as to the matters contained below and filed this Amendment Number 1 to Form 10-Q to amend the Company’s Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2008. Our reassessment is based on: (a) the matters addressed in September 19, 2008 comment letter; (b) consultation with our legal counsel; (c) consultation with our independent registered public accounting firm; and (d) our review of: (i) “Internal Control over Financial Reporting - Guidance for Smaller Public Companies published by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”); (ii) Internal Control over Financial Reporting - Guidance for Smaller Public Companies published by COSO; and (iii) various SEC releases and SEC interpretative guidance regarding internal control over financial reporting.
 
This Amendment Number 1 to our Form 10-Q amends Item 4T of Part I of Form 10-Q and the Principal Executive Officer and Principal Financial Officer Certifications under Item 601(b)(31) of Regulation S-B (the “Amended Items”). In accordance with Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the amended items have been amended and restated in their entirety. No attempt has been made in this Amendment Number 1 to our Form 10-Q to modify or update other disclosures as presented in the original Form 10-Q.
 
Item 4T. Controls and Procedures
  
Evaluation of Disclosure Controls and Procedures:
 
We maintain disclosure controls and procedures, as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act that are designed to insure that information required to be disclosed in the reports we file or submit under the Exchange Act is recorded, processed, summarized and reported within the periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer/Chief Financial Officer, or the persons performing similar functions, to allow timely decisions regarding required disclosure.

As previously disclosed in Amendment Number 2 to our Form 10-KSB for the year ended December 31, 2007, we concluded that our disclosure controls and procedures were ineffective as of December 31, 2007. The fact that we filed our Form 10-KSB thirty (30) days late was attributable to having ineffective disclosure controls and procedures. We have also previously disclosed in Amendment Number 2 to our Form 10-Q for the quarterly period ended March 31, 2008 that our disclosure controls and procedures were ineffective as of March 31, 2008.
 
Under the supervision and participation of our Chief Executive Officer/Chief Financial Officer, or the persons performing similar functions, our management has evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this quarterly report. Based on that evaluation, our Chief Executive Officer/Chief Financial Officer, or the persons performing similar functions, concluded that our disclosure controls and procedures were ineffective as of June 30, 2008.
 


Specifically, in Amendment Number 2 to our Form 10-KSB for the year ended December 31, 2007 we outlined certain steps that we felt were necessary to strengthen our disclosure controls and procedures, in order to evaluate and remedy the deficiencies and to test these procedures and controls on an ongoing basis. Those steps are repeated below:
 
 
1.
We are seeking to hire a Chief Financial Officer, or an employee who will perform the functions of a Chief Financial Officer, who will strengthen our disclosure controls and procedures by implementing procedures that enhance the recording, processing, summarizing and reporting of the information which we are required to file within the time periods specified in the Commission’s rules and forms. This individual will also be responsible for simplifying certain accounting procedures and arrange for the training of any additional accounting personnel that we may hire in the future, which will be beneficial to strengthening our disclosure controls, expand our documentation of accounting transactions and related reviews, improve the timeliness and quality of financial reports to management, and improve the communication between our accounting/finance department and all sectors of our business;
     
 
2.
We will increase our use of outside advisors to improve our quality of disclosure.

As of June 30, 2008 we had not yet hired a full time Chief Financial Officer to perform the functions described above as a result, we have concluded that our disclosure controls and procedures were ineffective as of June 30, 2008. We will continue to seek to hire a qualified Chief Financial Officer or an employee to perform the functions described above. Currently we rely on the services of an outside consultant to assist management in performing these functions.
 
Evaluation of Changes in Internal Control over Financial Reporting:
 
Under the supervision and with the participation of our Chief Executive Officer/Chief Financial Officer, or those persons performing similar functions, our management has evaluated changes in our internal controls over financial reporting that occurred during the second quarter of 2008. Based on that evaluation, our Chief Executive Officer/Chief Financial Officer, or those persons performing similar functions, did not identify any change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
 
Important Considerations:
 
The effectiveness of our disclosure controls and procedures and our internal control over financial reporting is subject to various inherent limitations, including cost limitations, judgments used in decision making, assumptions about the likelihood of future events, the soundness of our systems, the possibility of human error, and the risk of fraud. Moreover, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions and the risk that the degree of compliance with policies or procedures may deteriorate over time. Because of these limitations, there can be no assurance that any system of disclosure controls and procedures or internal control over financial reporting will be successful in preventing all errors or fraud or in making all material information known in a timely manner to the appropriate levels of management.
 

 
SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant has caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

OPTIGENEX INC.  
 
/s/ Daniel Zwiren
Daniel Zwiren
Chief Executive Officer
 
Dated: October 14, 2008


In accordance with the Exchange Act, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
 
Signature
 
Title
 
Date
 
 
 
 
 
/s/ Daniel Zwiren 
 
Chairman of the Board
Chief Executive Officer (Principal Executive Officer)
Chief Financial Officer (Principal Accounting Officer)
 
October 14, 2008
Daniel Zwiren
 
 
 
 
 

Optigenex (CE) (USOTC:OPGX)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024 Optigenex (CE) 차트를 더 보려면 여기를 클릭.
Optigenex (CE) (USOTC:OPGX)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024 Optigenex (CE) 차트를 더 보려면 여기를 클릭.